Northeast Pharmaceutical Group Co Ltd Financial Flexibility Index
Northeast Pharmaceutical Group Co Ltd financial flexibility index. Northeast Pharmaceutical Group Co Ltd (000597) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥285.57 Million (operating CF CN¥274.09 Million minus capex CN¥11.48 Million) represents 0% of total liabilities (CN¥8.05 Billion). See 000597 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Northeast Pharmaceutical Group Co Ltd (1998–2025)
Financial flexibility index of Northeast Pharmaceutical Group Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Northeast Pharmaceutical Group Co Ltd across 28 annual periods. Check 000597 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Northeast Pharmaceutical Group Co Ltd Financial Flexibility Index by Year (1998–2025)
Northeast Pharmaceutical Group Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Northeast Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Northeast Pharmaceutical Group Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.17x | CN¥1.20 Billion | CN¥1.11 Billion | CN¥7.22 Billion | ▲ +61.2% |
| 2024 | 0.10x | CN¥918.19 Million | CN¥758.76 Million | CN¥8.88 Billion | ▲ +27.3% |
| 2023 | 0.08x | CN¥822.18 Million | CN¥586.75 Million | CN¥10.11 Billion | ▼ -45.3% |
| 2022 | 0.15x | CN¥1.35 Billion | CN¥1.11 Billion | CN¥9.10 Billion | ▲ +52.6% |
| 2021 | 0.10x | CN¥866.31 Million | CN¥746.51 Million | CN¥8.89 Billion | ▼ -19.3% |
| 2020 | 0.12x | CN¥971.30 Million | CN¥570.92 Million | CN¥8.04 Billion | ▲ +79.0% |
| 2019 | 0.07x | CN¥581.77 Million | CN¥352.60 Million | CN¥8.62 Billion | ▼ -35.6% |
| 2018 | 0.10x | CN¥850.83 Million | CN¥285.09 Million | CN¥8.13 Billion | ▲ +642.6% |
| 2017 | 0.01x | CN¥113.43 Million | CN¥-301.20 Million | CN¥8.05 Billion | ▼ -81.5% |
| 2016 | 0.08x | CN¥561.52 Million | CN¥384.51 Million | CN¥7.36 Billion | ▲ +7.7% |
| 2015 | 0.07x | CN¥445.74 Million | CN¥99.70 Million | CN¥6.29 Billion | ▼ -28.9% |
| 2014 | 0.10x | CN¥579.26 Million | CN¥46.99 Million | CN¥5.81 Billion | ▲ +219.8% |
| 2013 | 0.03x | CN¥185.64 Million | CN¥-266.38 Million | CN¥5.96 Billion | ▼ -50.1% |
| 2012 | 0.06x | CN¥264.99 Million | CN¥86.09 Million | CN¥4.24 Billion | ▲ +36.9% |
| 2011 | 0.05x | CN¥188.33 Million | CN¥-233.32 Million | CN¥4.13 Billion | ▼ -77.9% |
| 2010 | 0.21x | CN¥729.89 Million | CN¥255.96 Million | CN¥3.54 Billion | ▼ -43.9% |
| 2009 | 0.37x | CN¥1.48 Billion | CN¥615.91 Million | CN¥4.03 Billion | ▼ -13.0% |
| 2008 | 0.42x | CN¥1.07 Billion | CN¥709.03 Million | CN¥2.53 Billion | ▲ +218.9% |
| 2007 | 0.13x | CN¥286.34 Million | CN¥198.56 Million | CN¥2.16 Billion | ▲ +391.5% |
| 2006 | -0.05x | CN¥-58.16 Million | CN¥-106.00 Million | CN¥1.28 Billion | ▼ -129.5% |
| 2005 | 0.15x | CN¥215.06 Million | CN¥111.40 Million | CN¥1.40 Billion | ▼ -12.4% |
| 2004 | 0.18x | CN¥272.20 Million | CN¥211.06 Million | CN¥1.55 Billion | ▼ -8.7% |
| 2003 | 0.19x | CN¥317.54 Million | CN¥230.08 Million | CN¥1.65 Billion | ▲ +77.8% |
| 2002 | 0.11x | CN¥195.48 Million | CN¥157.41 Million | CN¥1.81 Billion | ▲ +61.5% |
| 2001 | 0.07x | CN¥125.42 Million | CN¥78.84 Million | CN¥1.87 Billion | ▲ +144.5% |
| 2000 | 0.03x | CN¥48.31 Million | CN¥36.13 Million | CN¥1.76 Billion | ▼ -25.9% |
| 1999 | 0.04x | CN¥64.03 Million | CN¥54.62 Million | CN¥1.73 Billion | ▲ +324.9% |
| 1998 | 0.01x | CN¥13.84 Million | CN¥-7.59 Million | CN¥1.59 Billion | — |